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1. Introduction  
Reliable and sustained access to the circulation is mandatory for the provision of long-term 
hemodialysis which is critical to the survival of patients with end-stage renal disease 
(ESRD). An ideal vascular access provides adequate blood flow to meet the hemodialysis 
prescription, with minimal complications due to infection or thrombosis. The natural 
arteriovenous fistula (AVFs) comes closest to meeting these criteria while arteriovenous 
grafts (AVGs) and central venous catheters (CVCs) present other vascular access options. In 
the United States, promoting a major shift in using fistula as first-choice vascular access has 
been strongly recommended by the 2001 Kidney Disease Outcome Quality Initiative 
(K/DOQI) vascular access guideline (NKF-DOQI 2001) and the “Fistula First” national 
initiative (Tonnessen et al 2005). Ideally, every patient would initiate dialysis with a mature 
fistula suitable for cannulation. In real clinical setting, this is not true due to combination of 
the following factors including (i) lacking nephrology follow-up at the time of ESRD, (ii) late 
nephrology referral, (iii) poor or no planning of fistula placement, (iv) inadequate fistula 
maturation and (v) poor vascular preparation due to prior venous cannulation.  
In current practice, 20-50% of attempted AVFs fail to mature adequately. Despite a recent 
increase in the number of prevalent patients dialyzing with an AVF (47%) in the US 
following the fistula-first initiative, 28% of prevalent patients remain dependent on an AVG 
and 25% on a CVC. In Canada, recent data demonstrate that 50% of patients use an AVF, 
while 39% and 11% depends on a CVC or AVG, respectively (James et al 2009).  
Sadly, hemodialysis CVCs are increasingly being introduced in patients requiring 
emergency or chronic renal replacement therapy. Table 1 outlines the advantages and 
disadvantages of CVCs. The percentages of patients undergoing dialysis with vascular 
catheters are increasing in Europe, ranging from 15% (Germany) to 50% (United Kingdom) 
of all hemodialysis patients. In the United States, up to 60% of patients start hemodialysis 
with CVCs (Pisoni et al 2002). Over the last decade, the number of patients using CVCs for 
hemodialysis doubled (Rayner et al 2004). According to the Dialysis Outcomes and Practice 
Patterns Study, 18% of patients with end-stage renal failure in the United States and 24% of 
those in Great Britain have been dialysed with such catheters (Quarello et al 2006). Table 2 
summarizes the indication for using CVCs. Recent studies indicate that CVCs are used in 20-
25% of incident (<6 months) chronic kidney disease (CKD) stage 5 patients and still used in 
10-20% of prevalent hemodialysis patients (> 6 months) (Rayner et al 2004a, Moist et all 
2007). The use of CVCs has been complicated by higher rates of thrombosis, dysfunction, 
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and infection compared with AVFs. As a result of this, maintaining CVCs is associated with 
high costs (Lacson et al 2007). The increased use of CVCs requires a maximal precaution in 
its management and a stringent practice to reduce its risk and complications. 
 
Advantages Disadvantages 
High success rate High morbidity caused by thrombosis and infection 
Insertion into multiple sites 
 
Risks of permanent central venous stenosis or 
occlusion 
Maturation time not required Lower blood flow rates requiring a longer dialysis time 
No venepuncture  
No hemodynamic consequences   
Easy replacement   
Functional for months  
(chronic tunneled CVC) 
 
Ease of correcting thrombotic 
complications 
 
Table 1. Advantages and disadvantages of central venous catheters for hemodialysis 
 
 Pending maturation of arteriovenous fistula 
 Providing temporary dialysis treatment for patients undergoing maintenance 
peritoneal dialysis but complicated by peritonitis such that the infection can be 
controlled and the peritoneum be rested 
 Awaiting for living-related donor transplantation 
 “Bridging dialysis” followed failed previous vascular or peritoneal access allowing 
planning of long-term access 
 Permanent vascular access when other sites for arteriovenous fistula or grafts are 
exhausted 
Table 2. Indications for central venous hemodialysis catheters 
2. Types of central venous catheters 
There are two main categories of hemodialysis catheters: (i) non-tunneled, uncuffed, 
designed for short-term venous access of up to three weeks and (ii) tunneled, cuffed 
catheters for longer use. An ideal CVC is biologically neutral and does not induce venous or 
catheter lumen thrombosis; its surface is coated with an agent, which prevents migration 
and multiplication of bacteria. It should enable continuous dialysis with the blood flow 
through the catheter > 350-400 ml/min. Moreover, it ought to be non-traumatic, soft, easy to 
insert, mechanically durable, bending-resistant, comfortable for the patient and inexpensive. 
A comparison of acute and chronic central venous catheters is shown in Table 3. 
i. Temporary acute catheters 
Acute untunneled CVCs are used in emergency situations (dialysis, plasma exchange, 
hemofiltration or hemoperfusion) or as a short-term bridging access (ideally < 7 days). The 
advantages of these catheters are their ease of insertion (even by the bedside), the ability to 
insert them in multiple sites in almost any patient and the lack of hemodynamic 
compromise associated with their use. Internal jugular vein is the preferred site as 
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anatomically this provides the most direct route to the superior vena cava and right atrium. 
The vein should be localized by ultrasound (+/- Doppler). Insertion into the left internal 
jugular vein is associated with a higher incidence of central stenosis and poorer patency. For 
selected cases requiring short-term dialysis, the femoral vein can also be used. Subclavian 
vein should be discouraged as it may jeopardize the long-term arteriovenous access options 
with complication of subclavian stenosis. The catheters are usually inserted using the 
Seldinger technique. The catheter can be used immediately after confirming correct 
placement with fluoroscopy.  
 
Acute Chronic 
For use of < 7 days For use of > 3 weeks 
Most are not tunneled and without a 
retention cuff - conical tip for easy insertion 
Most are tunneled with a retention  
cuff - soft tip 
Most are dual lumen with venous port 2-3 
cm distal of arterial port 
Thermoplastic polyurethane – larger 
internal diameter, biocompatible, 
nonthrombogenic  
Polyurethane – stiff and withstanding high 
pressure 
Carbothane – copolymer with strength for 
longevity and softness for flexibility  
Silicone – larger lumen but needs a  
peel-away sheath  
 
Silicone – larger lumen but needs a  
peel-away sheath, biocompatible,  
less thrombogenic 
Table 3. Comparison between acute and chronic central venous catheters 
To ensure continuous, independent blood flow, catheters are double–lumen. The distal part 
has two separate openings; one collecting the patient`s blood − “arterial”, located 2-3 cm 
from the catheter end and the second one pumping the blood to the patient − “venous”, 
placed at its end. Temporary catheters are usually made of stiff materials: polyurethane or 
polyvinyl, and thus are easier to introduce along the guidewire and a hemostasis valve is 
not needed. The sharp distal tip facilitates the insertion through the subcutaneous tissues. 
Compared to soft catheters, they are more resistant to bending in the vessel. At body 
temperature, after contact with the bloodstream, they become plastic, which reduces the risk 
of vessel damage. Temporary CVCs have no cuffsbut are quipped with dacron muffs. The 
insertion doe not require “tunnelization”, thus fast access to the circulatory system can be 
provided. They vary in length, therefore the proper choice is easier depending the puncture 
site and availability of a central vessel. They may be used for several days or up to three 
weeks. Their main advantage is easy insertion into the vessel using the Seldinger technique 
with easy replacement not requiring expensive accessory devices, (which may not be always 
available) such as fluoroscopy or ultrasound. Generally, the blood flow through temporary 
CVCs is limited to 200-250 ml/min. 
The newer catheters are made of silicone with bigger internal diameter which ensures the 
blood flow of 400 ml/min. Some of them are tunneled. Silicone is thermoset and thus the 
catheter is soft. Hence it has to be inserted using a dilator and peel-away sheath. Other 
materials include polyurethane which is thermoplastic and softens at body temperature. 
This reduces endothelial damage and thrombogenicity (Leblanc et al 1997). The tunneled 
catheters can be introduced either antegrade (skin to insertion site) or retrograde (insertion 
site to skin). The position of soft CVCs should be confirmed by fluoroscopy.  
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ii. Long-term tunneled catheters 
Tunneled CVCs with cuffs are made of silicone, silastic or carbothane elastomer, 
polyurethane co-polymer and polycarbonate − these materials are softer and more plastic 
than those used in temporary catheters. Therefore, they are usually inserted using the 
Seldinger technique via peel-away sheath. Subcutaneous tunnelization and a cuff are to 
stabilize the catheter and prevent the spread of infections. The soft silastic elastomer enables 
the placement of the distal catheter tip in the right atrium, which should be confirmed by 
fluoroscopy. Bigger internal diameters (thicker catheters) provide better blood flows and a 
wider dilator or sequential dilator is frequently used.  
The first model of a tunneled catheter was PermCath, an oval catheter with two circular 
canals. Subsequent models (e.g. Vas Cath) were designed with an internal septum dividing 
the internal lumen into two parts. The oval transverse section of the catheter facilitated its 
insertion through the peel-away sheath. The third popular option was the introduction of 
two catheters with a single lumen – Tesio or its modification. One collected the blood 
through the opening in the superior vena cava and the other one supplied blood through the 
opening in the right atrium. Other than the catheter body and lumen, the design of the 
shape of catheter tips is also emphasized for better blood flow, improved reliability and 
minimizing recirculation (Ash 2008). 
The newest catheters implanted surgically are equipped with a subcutaneous port (Morgan 
2001, Ross 2001), which reduces percutaneous device-related complications. In most cases, 
the port consists of a chamber made of a titanium, ceramics or other neutral plastic materials 
with silicone membrane and an attachable catheter. The silicone membrane enables repeated 
penetrations (about 1000-2000), depending on the product and size of the puncture needle. 
The entire system is placed under the skin, which prevents infections or accidental opening. 
There are different configurations of the catheter and port chamber from using two single 
catheters each attached to a single chamber port to a double-lumen catheter connected to a 
two-chamber port. The vascular port implantation is based on the same principles as those 
for central venous access except the ports are placed in a subcutaneous pocket. The port can 
be punctured with normal hemodialysis needles or needles with special make that does not 
cut an opening in the membrane. The main reason of low popularity of hemodialysis ports 
is their relatively high cost.  
3. Percutaneous insertion of central venous catheter 
As mentioned, the right internal jugular vein is the preferred site as the curve of the catheter 
is straight thus achieving the best result. If the left internal jugular vein is used, negotiation 
of the curve at the venous entry to the superior vena cava may require experience and care. 
Moreover, one must choose a longer catheter as compared with right jugular vein puncture. 
The length of catheter introduced from neck or thoracic access should enable its distal end to 
reach the right atrium when a soft catheter is used or be placed in the superior or inferior 
vena cava when the catheter is stiff. It is recommended to place hemodialysis CVCs under 
fluoroscopic screening to avoid trauma with the guidewire in the inferior vena cava during 
insertion and the distal part of catheter in the upper right atrium upon completion of 
placement (Lin et al 1998, Keenan 2002).  
The first choice for catheterization is the right internal jugular vein, followed by the right 
external jugular vein, left internal jugular vein, left external jugular vein, and finally femoral 
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veins or external iliac veins (Maya et al 2005). The vein should be localized by ultrasound 
and can be differentiated from the artery by Doppler. The probe should first be placed on 
the head of the sternomastoid muscle and then moves down towards the clavicle. The 
puncture site should be as low as possible but above the clavicle whereas the exit of the 
subcutaneous tunnel should preferably be below the clavicle. 
Femoral and external iliac veins may be used for CVC insertion in bed-ridden patients or in 
the intensive care setting, particularly in patients requiring artificial lung ventilation, after 
head and neck trauma with numerous catheters and drains of the neck and thorax as well as 
those with tracheostomy (Zaleski et al 1999, Mathur et al 1993). Patients with kidney 
transplant potential should avoid femoral vein catheterization. With catheter insertion in the 
groin, meticulous hygiene of the puncture site is required. The patency period from the 
insertion to removal is markedly shorter in femoral vein access compared to catheters 
inserted through the internal jugular vein. 
4. Catheterization-related complications  
 
Irrespective of the type (non-tunneled or tunneled) or design (straight or with formed shape), 
their use is likely to be associated with complications (Table 4) (Morgan 2001, Ross 2001).  
 
Early Late 
Inadvertent arterial puncture and central 
vessel perforation 
Infection 
 
Hemothorax Central vein thrombosis 
Pneumothorax Catheter thrombosis formation  
Pericardial tamponade Central vein stenosis  
Atrial perforation Catheter dysfunction  
(can be early due to kinking) 
Dissection/occlusion of carotid artery Permanent vascular ingrowth 
Arrthymias   
Air embolism  
Retroperitoneal hemorrhage  
(for femoral vein insertion) 
 
Primary failure – technical error  
Table 4. Complications of central venous catheters insertion 
The incidence of complications reaches 5.9% with catheter insertion based only on 
topographic anatomy even with experienced clinicians (McDowell et al 1993). In contrast, 
the incidence of procedure-related complications in central venous catheterization under 
ultrasound guidance is only 0.8% (Trerotola et al 1997). Ultrasound-guided catheterization 
also limits the incidence of failures related to catheter insertion and reduces complications 
and necessity of multiple punctures of a vessel (Randolph et al 1996). Early complications 
which are mainly “surgical” include pneumothorax, pleural or mediastinal hemotoma, air 
embolism, thoracic tract injury, damage to nervous structures within the neck and thoracic 
region, puncture of the cardiac cavities, or cardiac arrest (Feldman et al 1996) (Figure 1). 
Non-surgical complications include cardiac arrhythmia and insertion site infection. 
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Fig. 1. Plain Chest Xray showing a CVC placed in the left internal jugular vein protruding 
out of the vessel wall (arrow)  
Long-term complications are equally important. The common ones are thrombotic 
complications, vascular stenosis and catheter-related bacteremia (CRB). To reduce their 
complications, the internal surface of catheters is often coated with heparin. Coating or 
impregnation of catheters with silver salts and antibiotics reduces the colonization of 
bacteria.  
4.1 Catheter dysfunction 
The 2006 National Kidney Foundation K/DOQI guidelines defines access dysfunction as the 
inability to achieve blood flow (Qb) ≥ 300 ml/min during the first 60 minutes of hemodialysis 
despite at least one attempt to improve flow (National Kidney Foundation 2006). Since then, 
larger bore catheter design allows much higher Qb (> 400 ml/min) to be achieved at the same 
prepump pressure. Hence, waiting until Qb declines to 300 ml/min in these catheters may be 
inappropriate, missing the opportunity to detect catheter dysfunction earlier. 
Early identification of catheter dysfunction enables prompt intervention and salvage. 
Catheter occlusion can be caused by kinking or malposition and these may be detected 
during the first hemodialysis session. Other causes of catheter dysfunction include leakage, 
drug precipitation, thrombus formation and growth of a fibrin sheath. Thrombus-related 
occlusion typically occurs late either with or without a fibrin sheath. The clinical features of 
different thrombotic occlusive complications are summarized in Table 5. Catheter 
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dysfunction is frequently associated with recirculation that exerts a deleterious effect on 
dialysis efficiency and patient outcome (Leblanc et al 1997).  
 
Complications Features Symptoms
Mural thrombus 
 
Fibrin from vessel wall injury 
connected to fibrin-coated catheter 
leading to increased risk of venous 
thrombosis
Leakage of infusate from 
the insertion site, 
swelling, pain, 
tenderness, engorged vein 
Intraluminal 
thrombus 
 
Fibrin forms inside the catheter 
lumen causing partial or completion 
occlusion 
Unable to infuse and/or 
withdraw blood 
Fibrin sheath 
 
Fibrin adheres to the external surface 
encasing the catheter and frequently 
extending the length of the catheter; 
thrombi trapped between sheath and 
catheter tip 
Unable to infuse and/or 
withdraw blood 
Fibrin tail or flap 
 
Fibrin extends from the end of the 
catheter causing partial occlusion 
(fibrin tail acts as an one-way valve) 
Able to infuse but not 
withdraw blood 
Table 5. Different thrombotic occlusive complications related to central venous catheter for 
dialysis 
Before the tunneled CVC thrombosis occurs, prophylactic inhibition of coagulation cascade 
should be considered. The earlier results of various antiplatelet agents and anticoagulation 
were not encouraging. Better patency has been maintained with catheter locking solutions 
between dialysis sessions. The standard protocol has been heparin instillation (1000 to 10000 
units/ml) into the lumens in a volume sufficient to fill to the lumen tip (the lock). The 
heparin concentration is reduced because catheter lumens have increased in volume so as to 
reduce the possibility of unintentional systemic anticoagulation. Trisodium citrate with its 
antithrombotic and potentially antibacterial properties has also been tested as a locking 
solution. The American Society of Diagnostic and Interventional Nephrology Clinical 
Practice Committee recommends using a locking solution of 1000 units/ml heparin or 4% 
trisodium citrate to maintain CVC patency (Fuchs et al 1999). 
Most recently, a Canadian multicenter study showed the once weekly use of recombinant 
plasminogen activator (1 mg in each lumen), as compared with heparin (5000 units/ml) 
thrice weekly, as a locking solution for CVC significantly reduced the incidence of catheter 
dysfunction and bacteremia (Hemmelgarn et al 2011). 
4.2 Central thrombosis formation 
Mural thrombosis in the superior vena cava and the right atrial wall associated with CVC 
placement is detected in one-third of patients but often remains asymptomatic [26]. 
Treatment by infusion of a fibrinolytic agent produces good results but angioplasty and 
stenting may be required for organized thrombosis. 
4.3 Central vein stenosis  
The incidence of central vein stenosis is considerable. As with fibrin sheath, central vein 
stenosis should be identified with a superior vena cavogram performed by removing the old 
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catheter over the working guidewire followed by a pigtail catheter insertion (Figure 2). The 
management of central stenosis is evolving. Whenever found, endovascular balloon 
angioplasty should be attempted to a minimum of the contiguous uninvolved vein (Quinn 
et al 1995). Unfortunately, central vein stenosis tends to recur (Quinn et al 995, Kovalik et al 
1994). The use of flexible stents has gained popularity recently despite the long term 
outcome is not well defined.  
 
 
Fig. 2. Patient with a non-functioning left internal jugular vein hemodialysis catheter. Left 
subclavian venogram showed stenosis at proximal superior vena cava (arrow) with multiple 
collaterals in the neck (arrowheads). 
4.4 Fibrin sheath 
Fibrin sheaths account for 13-57% of catheter dysfunction (Suhocki et al 1996). The 
formation begins 24 hours after placement and it develops into a full-length sleeve after 5-7 
days (Faintuch et al 2008). The sheath first occurs when fibrin adheres to the external surface 
before encasing the catheter and frequently extending the length of the catheter. The sheath 
seems to originate from the insertion site or the cuff and tends to migrate down the length of 
the catheter causing occlusion. Thrombi may also be trapped between sheath and catheter 
tip. A permcathogram done by injecting contrast through the catheter ports under 
fluoroscopic screening may show a persisting filling defect at the catheter tip or reflux of the 
contrast along the sheath in a retrograde direction (Figure 3). Fibrin sheaths may be treated 
by prolonged infusion of fibrinolytic agents (urokinase 30000 units/hour via each port x 4 
hours or recombinant tissue plasminogen activator of 2.5 mg diluted in 50 ml normal saline 
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at a rate of 17 ml/hour through each port x 3 hours), mechanical stripping using a snare 
inserted via the femoral vein by exchange of catheter over a guidewire (Suhocki et al 1996, 
Faintuch et al 2008, Goldberg et al 1985). Diverse degree of success in fibrin sheath stripping 
is reported from different centers.  
 
 
Fig. 3. (A) A fibrin sheath (arrow) formed inside the lumen of the CVC. (B) A 
permcathogram done showing a persisting filling defect (arrow) in the catheter lumen and 
reflux of the contrast at the catheter tip.  
4.5 Catheter-related bacteremia 
Catheter infection is a major cause of morbidity and mortality responsible for 6-28% of 
catheter failures (Bagui et al 2007). Diagnosis of catheter-related bacteremia (CRB) requires 
at least one of the following criteria: (a) clinical exit site infection with evidence of 
inflammation within 2 cm of sites; (b) definite organism grew from blood culture and 
catheter with no other apparent source of infection; (c) probable blood stream infection with 
defervescence after catheter removal when both blood and catheter tip infection is not 
confirmed in a symptomatic patients with no apparent source of infection; (d) possible 
blood stream infection in a symptomatic patients with defervescence after catheter removal, 
but remains culture negative.  
The causative organisms are predominantly gram positive (~50%), gram negative bacilli 
(~25%) or polymicrobial (~20%). The most common occurrence is through the migration of 
skin organisms along the external surface of the catheter from the exit site wound or via the 
catheter lumen due to breakdown of aseptic technique. The organism can be embedded in a 
biofilm layer that confers protection from antibiotic therapy (Passerini et al 1992). Infection 
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occurs when the organisms on the catheter exceed a certain quantitative threshold. Ninety 
percent of exit site infections respond to oral antibiotics without the necessity of catheter 
removal. Oral antibiotics can be used for minor infection but intravenous antibiotics should 
be administered if there is a discharge from the tunnel /exit site. If the infection fails to 
resolve with these measures, the catheter should be removed and replaced through a 
different track. Systemic sepsis or bacteremia carries a higher morbidity. K/DOQI 
guidelines recommend rapid removal of catheters in unstable patients with bacteremia or in 
stable patients if remain symptomatic 36 hours after achieving serum concentration of 
bactericidal antibiotics. In these cases, antibiotics should be administered for 14-21 days. 
  
Reference Type of locking solution Intervention Control 
Dogra et al. 2002  Gentamicin 0.3 4.2 
McIntyre et al. 2004  Gentamicin 0.3 4.0 
Bleyer et al. 2005  Minocycline 0 0.472 
Kim et al 2006  Gentamicin/Cefazolin 0.4 3.1 
Saxena et al. 2006  Cefotaxime 1.7 3.6 
Nori et al. 2006  Gentamicin 0 4.0 
 Minocycline 0.4 4.0 
Filiopoulos et al. 2011  Gentamycin 2.7 9.9 
 Taurolidine/Citrate 3.7 9.9 
Allon 2003  Taurolidine 0.6 5.6 
Betjes and van Agteren 
2004  
Taurolidine 0 2.1 
Weijmer et al. 2005  Citrate (30%) 1.1 4.1 
                    Rate of CRB (per 1000 catheter-days) 
Table 6. Catheter locking solutions for prophylaxis against catheter-related bacteremia 
(CRB) 
Prophylaxis of catheter-related bacteremia has been studied with standard antibiotics or 
antimicrobial agents such as taurolidine and 30% citrate as catheter locking solution. Seven 
randomized clinical trials documented substantial efficacy of antibiotic locks (gentamicin, 
minocycline or cefotaxime) in prophylaxis against catheter-related bacteremia (Dogra et al 
2002, McIntyre et al 2004, Bleyer et al 2005, Kim et al 2006, Saxena et al 2006, Nori et al 2006, 
Filiopoulos et al 2011). An additional four studies documented reduction in frequency of 
catheter-related bacteremia using taurolidine or citrate as locking solution (Filiopoulos et al 
2011, Allon 2003, Betjes et al 2004, Weijmer et al 2005). These studies are summarized in 
Table 6.  
4.6 Permanent vascular ingrowth 
Tissue ingrowth into the catheter lumen occurs when the tissue entraps the catheter onto the 
endothelial surface of the vessel. There is no standard management for this problem. 
Surgical approach of a thoracotomy is required as cut down on to the internal jugular vein 
for catheter is not usually possible. 
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5. Other accesses for insertion of central venous catheter  
If the jugular veins are not accessible for long-term placement, the subclavian vein opposite 
the dominating side can be used. The nephrologist must realize the risk of subclavian 
stenosis (Feldman et al 1996, Can 2008). The subclavian vein should never be catheterized on 
the side of the unhealed arteriovenous fistula.  
 
 
Fig. 4. Transhepatic placement of a Retrocath (45 cm long, 16Fr) into the portal vein. 
Contrast was injected to confirm the successful cannulation of the portal venous system.   
Other alternative sites have been used for CVC placement when none of the typical central 
accesses is available. Such procedures must be conducted by an experienced interventional 
radiologist in a fully equipped facility. Alternative methods may be used: catheterization of 
the inferior vena cava, or hepatic, translumbar, renal, intercostal and mediastinal veins. 
The translumbar approach to cannulation of the inferior vena cava, first described in 1971, 
has gained renewed attention as an alternative method for CVC access. High adequacy 
dialysis with low rates of catheter-related infection has recently reported from a single 
center study (Power et al 2009). The catheter care protocols, a policy of clinically appropriate 
catheter salvage with empirical broad-spectrum antibiotics and prior experience with 
translumbar catheter may also have the influenced outcome.  
Transhepatic placement of hemodialysis catheter first described in 1994 can be associated 
with infrequent complications such as line sepsis, catheter migration, thrombosis and 
bleeding (Smith et al 204). These complications can be minimized when the procedure is 
performed by an interventional radiologist who is familiar with portal venogram (Figure 4) 
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(Yap et al 2010). In exceptional lack of options, transrenal access into the renal vein with 
consequent insertion of a tunneled catheter has been attempted (Murthy et al 2002). 
6. Conclusion  
Hemodialysis central venous catheters CVCs are commonly used in patients with renal failure 
requiring dialysis once other vascular options have been exhausted. Long-term catheters 
should be inserted using the Seldinger technique with a dilator and hemostasis valve under 
ultrasound guidance and fluoroscopic screening. Tunneled catheters with cuffs may be used 
both temporarily and permanently. The subcutaneous tunnel and cuff ensure stabilization of 
their position and limiting the migration of microorganisms on its external surface hence 
reducing the risk of infections. Finally, it must be emphasized that a well-functioning 
arteriovenous fistula is the best vascular access inducing the lowest number of complications. 
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